The Ministry of Health, Labor and Welfare will determine whether or not to approve a brand new drug for Alzheimer’s illness collectively developed by Japanese and American pharmaceutical firms on August 21, in line with interviews with individuals concerned. If permitted, it is going to be attainable to fabricate and promote the primary drug in Japan to work instantly on and take away the causative agent of Alzheimer’s illness.